<DOC>
	<DOCNO>NCT00462540</DOCNO>
	<brief_summary>The purpose study compare efficacy Formoterol Fumarate Inhalation Solution ( FFIS ) 20 mcg BID CombiventÂ® Inhalation Aerosol [ 2 inhalation meter dose inhaler ( MDI ) 18 mcg ipratropium bromide 103 mcg albuterol sulfate QID ] , Compare preference/compliance BID nebulization QID use MDI</brief_summary>
	<brief_title>A Crossover Study Treatment Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Diagnosis COPD Smoker exsmoker least 10 year smoke least one pack cigarettes per day Meet lung function requirement Diagnosis Asthma Significant disease COPD Female pregnant lactate plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>COPD</keyword>
	<keyword>Formoterol</keyword>
	<keyword>Ipratropium</keyword>
	<keyword>Crossover</keyword>
</DOC>